Photo taken from Tia Cheunkarndee/LinkedIn
May 20, 2024, 08:02
Tia Cheunkarndee: Our work on first line osimertinib for uncommon ex19del and compound EGFRm in NSCLC!
Tia Cheunkarndee, Medical Student at the Johns Hopkins University School of Medicine, shared a post on LinkedIn:
“So excited to share our work on 1L osimertinib for uncommon ex19del and compound EGFRm in NSCLC! Huge thanks to Susan Scott, Kristen A. Marrone, Matthew Guo, Johns Hopkins Thoracic Oncology for their mentorship on this project.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 4, 2025, 11:36
Apr 4, 2025, 11:09
Apr 4, 2025, 10:38
Apr 4, 2025, 10:16
Apr 4, 2025, 10:13